Replies to post #203306 on Biotech Values

[biomaven0]

>>moved extremely slow from initial pilot results too

Yes, agonizingly slowly. If I recall correctly they originally couldn't agree with the FDA on an endpoint so they tried some other indication that looked quicker.

Fibrosis is pretty much always going to have difficult endpoints, and the tricky PK of the drug also has slowed things.

[dewophile]

Thx

jq1234 pointed out that full data was at ASCO 2014 - here is the link.

http://meetinglibrary.asco.org/content/134242-144